The data suggested that the liver cancer cells viability of VV‐IL‐24 was obviously lower than that of luteolin, and the combination of VV‐IL‐24 with luteolin was significantly inhibited liver cancer cells viability than VV‐IL‐24 or luteolin alone and did not affect the proliferation of the normal liver cells LO2. Here, IL24 is linked to liver cancer.